Korea
  • Europe
  • Britain
  • Germany
  • France
  • Italy
  • Spain
  • Poland
  • Netherlands
  • Russia
  • Iran
  • Japan
  • Canada
  • Australia
  • Africa
  • AI
  • Korea
  • Bank of Korea
  • Coupang
  • Doosan
  • Hanwha
  • Hanwha Aerospace
  • Hanwha Ocean
  • HD Hyundai Heavy
  • Hyundai
  • Hyundai Motor
  • Kakao
  • Korea
  • Korea Exchange
  • LG
  • LG Electronics
  • LG Energy Solution
  • Naver
  • North Korea
  • POSCO
  • Pyongyang
  • Samsung
  • Samsung Biologics
  • Samsung Electronics
  • Seoul
  • SK
  • SK Hynix
  • SK Square
  • South Korea
Korea
  • Europe
  • Britain
  • Germany
  • France
  • Italy
  • Spain
  • Poland
  • Netherlands
  • Russia
  • Iran
  • Japan
  • Canada
  • Australia
  • Africa
  • AI
  • Korea

Browsing Category

Samsung Biologics

781 posts
SSamsung Biologics
Samsung Biologics' PolyPeptide Tender Offer Draws 97.98% Acceptance, Closing In on approximately $1.8 Billion Deal — BigGo Finance
Read More

Samsung Biologics’ PolyPeptide Tender Offer Draws 97.98% Acceptance, Closing In on approximately $1.8 Billion Deal — BigGo Finance

  • November 2, 2026
Samsung Biologics has effectively completed its share acquisition process for global peptide contract development and manufacturing organization (CDMO)…
SSamsung Biologics
Samsung Biologics secures 98% of PolyPeptide, moves to full takeover in Korea push
Read More

Samsung Biologics secures 98% of PolyPeptide, moves to full takeover in Korea push

  • November 2, 2026
A view of the Samsung Biologics headquarters in Songdo, Incheon./Courtesy of News1 Samsung Biologics(207940) secured 97.98% equity in…
SSamsung Biologics
Samsung Biologics has secured a 97.98% stake in the bid for Polypeptide Group, a global peptide cons..
Read More

Samsung Biologics has secured a 97.98% stake in the bid for Polypeptide Group, a global peptide cons..

  • November 2, 2026
Meet the Requirements for Compulsory Purchase of Remaining Shareholders of Minority Shareholders5th Announced Confirmation…Expected to close the acquisition…
SSamsung Biologics
{"text":"A view of the Samsung Biologics building"} - Seoul Economic Daily Culture News from South Korea
Read More

Samsung Biologics Wins 98% of PolyPeptide Shares in Tender Offer

  • November 2, 2026
{“text”:”A view of the Samsung Biologics building”} Samsung Biologics (207940.KS) secured a 97.98% acceptance rate in its tender…
SSamsung Biologics
Samsung Biologics closes tender offer for PolyPeptide Group, with 98% of shares tendered
Read More

Samsung Biologics closes tender offer for PolyPeptide Group, with 98% of shares tendered

  • November 2, 2026
Samsung Biologics recorded a final subscription rate of 97.98% in its tender offer for the global peptide contract…
SSamsung Biologics
The entrance to Samsung Biologics' headquarters in Songdo, Incheon. News1 - Seoul Economic Daily Finance News from South Korea
Read More

Samsung Biologics Labor Talks Stall Again as Union Vows Strike

  • November 2, 2026
The entrance to Samsung Biologics’ headquarters in Songdo, Incheon. News1 Wage and personnel-system negotiations between Samsung Biologics (207940.KS)…
SSamsung Biologics
News-Schriftzug auf schwarzem Hintergrund.
Read More

PolyPeptide Group: Provisional end result of the public tender offer of Samsung Biologics Co., Ltd.

  • November 2, 2026
PolyPeptide Group / Key word(s): Tender OfferPolyPeptide Group: Provisional end result of the public tender offer of Samsung…
SSamsung Biologics
Samsung Biologics labor talks stall as union plans job-by-job strikes in Korea
Read More

Samsung Biologics labor talks stall as union plans job-by-job strikes in Korea

  • November 2, 2026
Samsung Biologics headquarters in Songdo, Incheon. /Courtesy of News1 Management and labor at Samsung Biologics(207940), which have been…
SSamsung Biologics
A view of Samsung Biologics Plant 4 in Yeonsu-gu, Incheon. The Asia Business Daily archive.
Read More

Samsung Biologics: “Proposes Two-Week Delay in Labor Talks, Deems Dialogue Impossible”

  • November 2, 2026
Samsung Biologics proposed postponing labor-management negotiations, which were scheduled to resume on November 3, by two weeks. A…
SSamsung Biologics
Samsung Biologics
Read More

Samsung Biologics raises contract value with US pharma firm to W62.82b

  • November 2, 2026
CMO deal with US pharmaceutical company expanded by 30.3 billion won Contract value up 93% from previous disclosure,…
SSamsung Biologics
Samsung Biologics Labor-Management Negotiations Likely Delayed... Company Proposes 2-Week Postponement
Read More

Samsung Biologics Labor-Management Negotiations Likely Delayed… Company Proposes 2-Week Postponement

  • November 2, 2026
▲ Samsung Biologics Labor and management at Samsung Biologics, who have been locked in conflict for over half…
SSamsung Biologics
Samsung Biologics $185m Pfizer deal
Read More

Samsung Biologics $185m Pfizer deal

  • November 1, 2026
Pfizer becomes the seventh top 10 pharma firm to ink a deal with Korean CDMO Samsung Biologics. According…
Korea
www.europesays.com